The effects of discontinuing cinacalcet at the time of kidney transplantation

NDT Plus

Volumn 3, Issue 1, 2010, Pages 37-41

  Jadoul, Michel ^a   Baños, Ana ^b   Zani, Valter J ^c   Hercz, Gavril ^d  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b AMGEN LTD   (United Kingdom)

^c AMGEN INC   (United States)

^d HUMBER RIVER REGIONAL HOSPITAL   (Canada)

Author keywords

cinacalcet; end stage renal disease; kidney transplantation; secondary hyperparathyroidism

Indexed keywords

CINACALCET; PARATHYROID HORMONE; PLACEBO;

ADULT; ARTICLE; BIOCHEMICAL COMPOSITION; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIORITY JOURNAL;

EID: 77955952264     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfp167     Document Type: Article

References (18)

1. Block GA, Martin KJ, de Francisco ALM et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004; 350: 1516-1525
2. Lindberg JS, Culleton B, Wong G et al. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol 2005; 16: 800-807
3. Sterrett JR, Strom J, Stummvoll HK et al. Cinacalcet HCl (Sensipar/ Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism. Clin Nephrol 2007; 68: 10-17
4. Messa P, Maćario F, YaqoobMet al. The OPTIMA study: assessing a newcinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism. Clin J Am Soc Nephrol 2008; 3: 36-45
5. Moe SM, ChertowGM, CoburnJWet al.Achieving NKF-K/DOQITM bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 2005; 67: 760-771
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
7. Saha HH, Salmela KT, Ahonen PJ et al. Sequential changes in vitamin D and calcium metabolism after successful renal transplantation. Scand J Urol Nephrol 1994; 28: 21-27
8. Alsina J, Gonzalez MT, Bonnin R et al. Long-term evolution of renal osteodystrophy after renal transplantation. Transplant Proc 1989; 21: 2151-2158
9. Evenepoel P, Claes K, Kuypers D et al. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 2004; 19: 1281-1287
10. Serra AL, Savoca R, Huber AR et al. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant 2007; 22: 577-583
11. Serra AL, Schwarz AA,Wick FH et al. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1315-1319
12. Leca N, Laftavi M, Gundroo A et al. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Am J Transplant 2006; 6: 2391-2395
13. Kruse AE, Eisenberger U, Frey FJ et al. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1311-1314
14. Apostolou T, Damianou L, Kotsiev V et al. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet. Clin Nephrol 2006; 65: 374-377
15. Szwarc I, Argiĺes A, Garrigue V et al. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 2006; 82: 675-680
16. Apostolou T, Kollia K, Damianou L et al. Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet. Transplant Proc 2006; 38: 3514-3516
17. Srinivas TR, Schold JD, Womer KL et al. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol 2006; 1: 323-326
18. El-Amm JM, Doshi MD, Singh A et al. Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation. Transplantation 2007; 83: 546-549